Assessment of Proliferation Index with MIB-1 as a Prognostic Factor in Radiation Therapy for Cervical Cancer
- 1 November 2000
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 79 (2) , 300-304
- https://doi.org/10.1006/gyno.2000.5950
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Determination of Proliferation Index with MIB-1 in Advanced Ovarian Cancer Using Quantitative Image AnalysisAmerican Journal of Clinical Pathology, 1994
- Ki67 and AgNORs Staining in Squamous Cell Carcinoma of the Cervix: A ComparisonGynecologic and Obstetric Investigation, 1994
- Detection of the Ki‐67 antigen in fixed and wax‐embedded sections with the monoclonal antibody MIB1Histopathology, 1993
- Carcinoma of the cervix uteri: an assessment of the relationship of tumour proliferation to prognosisBritish Journal of Cancer, 1992
- Prognostic significance of the proportion of Ki-67-positive cells in adult t-cell leukemiaCancer, 1991
- Tumor growth fraction in cervical carcinomaGynecologic Oncology, 1991
- A comparative study of histopathology, hormone receptors, peanut lectin binding, ki-67 immunostaining, and nucleolar organizer region-associated proteins in human breast cancerCancer, 1991
- Ki-67 immunostaining in human breast tumors and its relationship to prognosisCancer, 1991
- Prognostic significance of Ki-67 reactivity in soft tissue sarcomasCancer, 1989
- Radioimmunoassay for tumor antigen of human cervical squamous cell carcinomaCancer, 1977